Our Clinical Research Facility
Learn more about our state-of-the-art Clinical & Laboratory facilities in Toronto, Canada
Take a Virtual Tour of our Toronto Clinical Research Facility
Toronto, Canada
Visit our Services Page to discover how BioPharma Services can become your trusted drug development partner.
Clinical Operation Capabilities
→ State-of-the-art Location (CA)
→ 150 bed subject capacity with superior accommodations
→ Phase 1 Clinical Trial ICU
→ BA/BE, Phase 1, HAP, PET & others
→ NHV and special populations
Bioanalysis Stronghold
→ 20,000 sample analysis capacity
→ LC/MS-MS Platform
→ 5x QTRAP 5500
→ 4x QTRAP 4000
→ ~50 MV/year
→ Watson LIMS
Data Management & Biostatistics Services
→ DMP and SAP development
→ Safety data management
→ Medical coding
→ Safety TLFs
→ CDISC (SDTM, ADaM)
BioPharma Services operates as a Global Leader for Clinical Research Services based in Toronto, Canada
Toronto, Canada | Research Facility
150-bed clinical unit
→ 3 BE clinic units with flexible design
→ 2 Phase 1 Clinical Trial Intensive Care Units (ICU)
In-house pharmacy unit
→ Licensed to store Schedule II drug products
→ Temperature and humidity controlled
→ Compounding and reconstitution capabilities
Support units
→ Subject recruitment call center
→ Screening unit
→ Sample processing laboratory
→ Freezer storage room (short and long term units)
→ Bioanalytical laboratory
→ Long term document archiving facility
Interested to learn more about BioPharma Services?
Watch one of our Informative Videos.
Quality. Trust. On Time Delivery. Every step of the way.
We know how hard it can be to select the right CRO for your drug development program. That’s why we work so hard to ensure that from the moment you contact us to schedule a discovery call, we are with you for every step of the journey.
BioPharma Services is a full service CRO that can help you take your compound from the protocol development stage right through to submission to regulatory agencies.
Schedule a Discovery Call
You can unsubscribe at any time. For more details, please read our Privacy Policy.